Oral Cancer: Page 24

Soligenix adds subjects for mucositis treatment study
By DrBicuspid.com staff writers
Biopharmaceutical company Soligenix has completed enrollment of additional subjects in the phase II study for its SGX942 oral mucositis treatment.
August 30, 2015
Week in Review: Enhanced oral cancer detection can save lives and protect from malpractice
By Tony Edwards
August 20, 2015
CDA Presents 2015: Enhanced oral cancer detection can save lives
By Donna Domino
SAN FRANCISCO - Enhanced oral cancer detection can help save patients' lives while protecting dentists from malpractice lawsuits, according to a presentation by Dr. Jonathan Bregman at this week's California Dental Association's CDA Presents 2015 meeting. Effective protocols for screening and high-tech detection devices will help stem the disease's growing incidence, especially among young people.
August 20, 2015
2015 08 20 14 30 18 240 2015 Cda Presents Thumb
UT gets $144K grant to study oral cancer pain
By DrBicuspid.com staff writers
The University of Texas (UT) Health Science Center at San Antonio has received a $144,000 grant from the American Cancer Society to study oral cancer pain.
August 16, 2015
MedImmune acquires rights to Inovio's HPV vaccine
By DrBicuspid.com staff writers
Inovio Pharmaceutial has entered into a license agreement with MedImmune for its INO-3112 immunotherapy for cancers caused by human papillomavirus (HPV) and also a collaboration to develop new cancer vaccines, the companies announced.
August 9, 2015
Curt Schilling supports Boston ban on smokeless tobacco
By DrBicuspid.com staff writers
Former Major League Baseball pitcher and oral cancer survivor Curt Schilling is supporting a Boston proposal to ban smokeless tobacco in public and private sports venues used by both amateurs and professionals.
August 5, 2015
Do HPV16 antibodies predict oral cancer survival?
By Donna Domino
A specific antibody to human papillomavirus type 16 (HPV16) improved the survival of patients with HPV-positive oropharyngeal squamous cell carcinoma in a new study in Clinical Cancer Research. Specific antibody status can be used to alter treatments for such patients.
August 5, 2015
2013 09 03 14 41 25 490 Hpv 200
CDC: Many U.S. adolescents not getting HPV vaccine
By Donna Domino
The number of 13- to 17-year-old boys and girls in the U.S. receiving the human papillomavirus (HPV) vaccine has increased for the second year in a row, but about half of all U.S. adolescents still haven't received it, according to a new report from the Centers for Disease Control and Prevention (CDC).
July 30, 2015
2013 09 03 14 41 25 490 Hpv 200
DrBicuspid.com Oral Cancer & Diagnostics Insider: HPV16 antibodies & survival rates
By Donna Domino
July 29, 2015
NYU researchers awarded $370K to study oral cancer pain
By DrBicuspid.com staff writers
The National Institute of Dental and Craniofacial Research has given two New York University (NYU) researchers a one-year award of nearly $370,000 to study pain relief for oral cancer.
July 28, 2015
July 27 is World Head and Neck Cancer Day
By DrBicuspid.com staff writers
An international group of head and neck oncology societies has deemed July 27 as World Head and Neck Cancer Day.
July 26, 2015
Study: Cancer-suppressing protein fades with age
By DrBicuspid.com staff writers
A protein that helps suppress oral and other cancers diminishes in skin and mouth epithelial cells as the human body ages, according to a study in the journal Aging Cell.
July 22, 2015
Previous Page
Page 24 of 116
Next Page